| |
| |
|
| Insider
Information: |
Lamond David |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
427,110 |
|
|
Indirect Shares
|
5,306,171 |
|
|
| Direct
Value |
$289,756 |
|
|
|
Indirect Value
|
$4,202,364 |
|
|
| Total
Shares |
5,733,281 |
|
|
| Total
Value |
$4,492,120 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cortexyme, Inc. |
CRTX |
Director |
2023-12-14 |
301,829 |
2023-12-14 |
4,082,267 |
Premium* |
|
|
Applied Molecular Transport Inc. |
AMTI |
Director |
2020-06-09 |
0 |
2022-05-23 |
1,077,519 |
Premium* |
|
|
Lucira Health, Inc. |
LHDX |
Director |
2021-02-09 |
125,281 |
2021-02-09 |
146,385 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-14 |
4 |
B |
$1.04 |
$23,532 |
I/I |
22,627 |
2,347,545 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-13 |
4 |
B |
$1.00 |
$22,627 |
I/I |
22,627 |
2,324,918 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-12 |
4 |
B |
$1.02 |
$22,774 |
D/D |
22,327 |
2,302,291 |
2.39 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-12 |
4 |
B |
$1.00 |
$300 |
I/I |
300 |
2,279,964 |
2.02 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-07 |
4 |
B |
$1.01 |
$19,314 |
I/I |
19,123 |
2,279,664 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-06 |
4 |
B |
$1.02 |
$19,505 |
I/I |
19,123 |
2,260,541 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-05 |
4 |
B |
$1.01 |
$19,314 |
I/I |
19,123 |
2,241,418 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-12-01 |
4 |
B |
$0.94 |
$13,515 |
I/I |
14,378 |
2,222,295 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-11-30 |
4 |
B |
$0.90 |
$12,940 |
I/I |
14,378 |
2,207,917 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-11-29 |
4 |
B |
$0.98 |
$14,090 |
I/I |
14,378 |
2,193,539 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-08-31 |
4 |
B |
$1.32 |
$54,154 |
I/I |
41,026 |
2,179,161 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-08-30 |
4 |
B |
$1.31 |
$53,744 |
I/I |
41,026 |
2,138,135 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-08-17 |
4 |
B |
$1.29 |
$31,948 |
I/I |
24,766 |
2,097,109 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-08-16 |
4 |
B |
$1.29 |
$151,379 |
I/I |
117,348 |
2,072,343 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2023-08-15 |
4 |
B |
$1.32 |
$142,410 |
I/I |
107,886 |
1,954,995 |
2.1 |
% |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2022-05-23 |
4 |
B |
$3.26 |
$109,210 |
I/I |
33,500 |
1,077,519 |
2.1 |
% |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2022-05-20 |
4 |
B |
$3.08 |
$101,640 |
I/I |
33,000 |
1,044,019 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
I/I |
200,002 |
1,734,722 |
0 |
- |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2021-04-06 |
4 |
B |
$42.00 |
$1,050,000 |
I/I |
25,000 |
1,011,019 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2021-03-24 |
4 |
B |
$33.77 |
$1,688,500 |
I/I |
50,000 |
1,847,109 |
2.1 |
% |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2021-03-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,534,720 |
1,534,720 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2021-03-04 |
4 |
B |
$34.28 |
$1,767,057 |
I/I |
50,000 |
1,797,109 |
2.1 |
% |
|
| LHDX |
Lucira Health, Inc. |
Director |
– • – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
146,385 |
146,385 |
0 |
- |
|
| LHDX |
Lucira Health, Inc. |
Director |
– • – |
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
125,281 |
|
- |
|
| AMTI |
Applied Molecular Transpo... |
Director |
– • – |
2020-06-09 |
4 |
A |
$0.00 |
$0 |
I/I |
914,589 |
914,589 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
